Surveillance of transmitted resistance to antiretroviral drug classes among young children in the western cape province of SOUTH AFRICA
dc.contributor.author | Van Zyl, G. U. | |
dc.contributor.author | Cotton, M. F. | |
dc.contributor.author | Claassen, M. | |
dc.contributor.author | Abrahams, C. | |
dc.contributor.author | Preiser, Wolfgang | en_ZA |
dc.date.accessioned | 2011-05-15T16:00:06Z | |
dc.date.available | 2011-05-15T16:00:06Z | |
dc.date.issued | 2010 | |
dc.description.abstract | There are limited data on transmitted antiretroviral resistance in young children who require antiretroviral therapy. We adapted the World Health Organization surveillance strategy, testing antiretroviral naive infants (<18 months) in the Western Cape Province of South Africa, and detecting only 3 non-nucleoside reverse transcriptase inhibitors (NNRTI) and no NRTI or protease inhibitor surveillance mutations in 49 patients. The estimated NRTI and protease inhibitor transmitted antiretroviral resistance prevalence is low (<5%), predicting good therapeutic response in Western Cape infants. Copyright © 2010 by Lippincott Williams & Wilkins. | |
dc.description.version | Article | |
dc.identifier.citation | Pediatric Infectious Disease Journal | |
dc.identifier.citation | 29 | |
dc.identifier.citation | 4 | |
dc.identifier.issn | 8913668 | |
dc.identifier.other | 10.1097/INF.0b013e3181c4dada | |
dc.identifier.uri | http://hdl.handle.net/10019.1/11524 | |
dc.subject | nevirapine | |
dc.subject | proteinase inhibitor | |
dc.subject | RNA directed DNA polymerase inhibitor | |
dc.subject | zidovudine | |
dc.subject | adolescent | |
dc.subject | analytic method | |
dc.subject | antiviral resistance | |
dc.subject | article | |
dc.subject | child | |
dc.subject | clinical article | |
dc.subject | drug surveillance program | |
dc.subject | genotype | |
dc.subject | highly active antiretroviral therapy | |
dc.subject | human | |
dc.subject | infant | |
dc.subject | mutation | |
dc.subject | preschool child | |
dc.subject | prevalence | |
dc.subject | priority journal | |
dc.subject | reverse transcription | |
dc.subject | school child | |
dc.subject | South Africa | |
dc.subject | treatment response | |
dc.subject | world health organization | |
dc.subject | Anti-HIV Agents | |
dc.subject | Drug Resistance, Viral | |
dc.subject | HIV Infections | |
dc.subject | HIV-1 | |
dc.subject | Humans | |
dc.subject | Infant | |
dc.subject | Mutation | |
dc.subject | Population Surveillance | |
dc.subject | Prevalence | |
dc.subject | Reverse Transcriptase Inhibitors | |
dc.subject | South Africa | |
dc.subject | World Health Organization | |
dc.title | Surveillance of transmitted resistance to antiretroviral drug classes among young children in the western cape province of SOUTH AFRICA | |
dc.type | Article |